FilingIndex
AGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-KAGSS10-KAMSS10-QPETVW10-KFMCQF11-KCTGO8-KBLTHS-1/AAURADEF 14AQLEP-UN8-KTOVXDEF 14AMLM8-KCURB424B5GL-PD8-KEXYNWS-1DLR-PJ8-KDFNSW8-KOTH8-K/APSKY8-KMODD10-KCTVA8-KSEQCS-1PPIH8-KOPRTDEFA14AAAVXF6-KMNRO11-KOPRTDEF 14AAIB8-KSWMR8-KRMCFDEF 14AALH8-KCVKD8-K
← CUE · Cue Biopharma, Inc.
DEFA14AThe Ballot

Cue Biopharma, Inc. files DEFA14A

Filed Apr 28, 2023 · 3y ago · Accession 0001193125-23-126907

Plain English

DEFA14A filed with the SEC.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Company
Cue Biopharma, Inc.
Ticker
CUE
CIK
1645460
Form type
DEFA14A
Filing date
Apr 28, 2023
Report date
—
Document
d452017ddefa14a.htm
Size
342 KB

More from CUE

8-KExecutive Change · Shareholder VoteJun 3, 20268-KExecutive Change · Company UpdateJun 2, 2026DEF 14AThe BallotMay 21, 202610-QThe RecordMay 14, 20268-KCompany UpdateMay 14, 20268-KExecutive Change · Material AgreementMay 1, 2026